Ding‐Chao Rong

508 total citations · 1 hit paper
10 papers, 329 citations indexed

About

Ding‐Chao Rong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ding‐Chao Rong has authored 10 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Ding‐Chao Rong's work include Heme Oxygenase-1 and Carbon Monoxide (2 papers), interferon and immune responses (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Ding‐Chao Rong is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (2 papers), interferon and immune responses (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Ding‐Chao Rong collaborates with scholars based in China, Australia and Taiwan. Ding‐Chao Rong's co-authors include Jie Mei, Peng‐Yuan Wang, Lei‐Yun Wang, Jun Zeng, Qian Hu, Hsuan-Shun Huang, Yunfei Lu, Haiying Wen, Zhongguo Zhou and Weiwei Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Small and Frontiers in Physiology.

In The Last Decade

Ding‐Chao Rong

9 papers receiving 322 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens

2023 174 citations Qian Hu, Ding‐Chao Rong et al. Frontiers in Bioengineering and Biotechnology profile →

Peers

Ding‐Chao Rong

MB

IMMUN

ONCOL

PFM

CR

Pengcheng Shi China

Hagit Baris Feldman Israel

Haoneng Tang China

Jia Gu China

Chengxin Luo China

Nupur Aggarwal United States

Xinwei Xu China

Ju-Eun Hong South Korea

Shi Liang China

Pengcheng Shi China

Ding‐Chao Rong

155 ×1.3

MB

40 ×0.6

IMMUN

59 ×1.1

ONCOL

28 ×0.6

PFM

48 ×1.0

CR

Citations per year, relative to Ding‐Chao Rong Ding‐Chao Rong (= 1×) peers Pengcheng Shi

Countries citing papers authored by Ding‐Chao Rong

Since Specialization

Citations

This map shows the geographic impact of Ding‐Chao Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding‐Chao Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding‐Chao Rong more than expected).

Fields of papers citing papers by Ding‐Chao Rong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ding‐Chao Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding‐Chao Rong. The network helps show where Ding‐Chao Rong may publish in the future.

Co-authorship network of co-authors of Ding‐Chao Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Ding‐Chao Rong. A scholar is included among the top collaborators of Ding‐Chao Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ding‐Chao Rong. Ding‐Chao Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Mei, Jie, Lei‐Yun Wang, Jun Zeng, et al.. (2025). Bronchoalveolar lavage fluid (BALF): Clinical applications for present and future. 3(1). 100115–100115.

2.

Mei, Jie, Xiaoye Zhang, Lei‐Yun Wang, et al.. (2025). Heme oxygenase 1 (HO-1) is a drug target for reversing cisplatin resistance in non-small cell lung cancer. Journal of Advanced Research. 80. 1121–1137. 4 indexed citations

3.

Rong, Ding‐Chao, Shan Chen, Hao Xu, et al.. (2025). ROS homeostasis in cell fate, pathophysiology, and therapeutic interventions. Molecular Biomedicine. 6(1). 89–89. 2 indexed citations

4.

Mei, Jie, Ding‐Chao Rong, Raymond C.B. Wong, et al.. (2024). Anoikis in cell fate, physiopathology, and therapeutic interventions. SHILAP Revista de lepidopterología. 5(10). e718–e718. 15 indexed citations

5.

Mei, Jie, Lei Cao, Ding‐Chao Rong, et al.. (2023). Disruption of Iron Homeostasis to Induce Ferroptosis with Albumin‐Encapsulated Pt(IV) Nanodrug for the Treatment of Non‐Small Cell Lung Cancer. Small. 19(49). e2206688–e2206688. 19 indexed citations

6.

Wang, Lei‐Yun, Xingjian Liu, Ying Zhu, et al.. (2023). The romantic history of signaling pathway discovery in cell death: an updated review. Molecular and Cellular Biochemistry. 479(9). 2255–2272. 14 indexed citations

7.

Hu, Qian, Ding‐Chao Rong, Lei‐Yun Wang, et al.. (2023). JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. Frontiers in Bioengineering and Biotechnology. 11. 1110765–1110765. 174 indexed citations breakdown →

8.

Xiao, Xiao, Weiwei Li, Ding‐Chao Rong, et al.. (2021). Human umbilical cord mesenchymal stem cells-derived extracellular vesicles facilitate the repair of spinal cord injury via the miR-29b-3p/PTEN/Akt/mTOR axis. Cell Death Discovery. 7(1). 212–212. 51 indexed citations

9.

Mei, Jie, et al.. (2021). CSF3 Is a Potential Drug Target for the Treatment of COVID-19. Frontiers in Physiology. 11. 605792–605792. 14 indexed citations

10.

Lu, Yunfei, et al.. (2020). Clinical characteristics and radiological features of children infected with the 2019 novel coronavirus. Clinical Radiology. 75(7). 520–525. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact